After exclusion, 100 men comprised the cohort for follow-up. The AAS cycle performed had a median duration of 13 weeks (range 2-52) and the average dose of AAS equivalents was 901 mg per week (range 250-3.382). Subjects used other performance and image enhancing drugs (PIEDs) such as growth hormone (21%). In total 272 AAS samples were analyzed and 47% contained the AAS indicated on the label. Nineteen percent had competed in bodybuilding competitions. One hundred and eleven men were seen for a baseline visit. Seventy-seven percent of participants had used AAS in the past and 97% of them had experienced side effects. The principal reason for AAS use was gain…